Nephrology CME

Credits: 0.50 CME
Penn State College of Medicine
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation: Examining Current and Future Strategies to Preserve Graft Function and Maximize Long-Term Outcomes
Titte R. Srinivas, MD, FAST
February 25, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Credits: 1.25 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
Stephen V. Liu, MD
February 12, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
Rishi P. Singh, MD
February 12, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
Richard S. Finn, MD
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
Axel Grothey, MD
February 8, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Checkpoint Inhibition in Gastrointestinal Cancers: Recent Advances in Gastric, Esophageal, and Colorectal Cancers and Their Application in Clinical Practice
Manish A. Shah, MD, FASCO
February 3, 2021
Credits: 1.00 CME / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
Anne H. Cross, MD, FAAN / Prof. Xavier Montalban
February 1, 2021
Credits: 0.75 CME
Medical Learning Institute, Inc.
Selective Inhibition of Oncogenic Transcription and Other Novel Approaches in the Treatment of Small Cell Lung Cancer: An Illustrative Guide to Navigating the Evolving Treatment Landscape and Integrating Latest Treatment Modalities Into Clinical Care
Jacob Sands, MD
January 29, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
Mark Crowther, MD, MSc, FRCPC, FRSC
January 26, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
Maria Arcila, MD
January 26, 2021
Credits: 1.50 CME / MOC / CE / CPE
The National Lipid Association
Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD
Professor Kausik Ray
December 31, 2020
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
Bruce Cree, MD, PhD, MAS
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
John Ravits, MD
December 31, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Precision Medicine in Hematologic Cancers: Lessons for Diagnostic and Treatment Protocols in CD30- and CD123-Expressing Disease
Steven M. Horwitz, MD
December 31, 2020
Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Reducing the Burden of Chronic Rhinosinusitis With Nasal Polyps on Patient Quality of Life: An Exploration of Novel and Emerging Biologic Therapy
Jonathan Corren, MD
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
Steven Brem, MD
December 29, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists
George L. Bakris, MD
December 29, 2020

Pages